Cosmos Pharmaceutical Corporation

Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.

Latest values as text and table

Cosmos Pharmaceutical Corporation

Cosmos Pharmaceutical Corporation (株式会社コスモス薬品, 3349), Retail Trade. 5 cross-shareholdings, a board of 6 and 10 largest shareholders, as filed on EDINET for the year to May 2026. EDINET filing S100YYDI, filed 2026-08-26. Source: company filings on EDINET (Financial Services Agency of Japan).

Financial summary

Five-year summary as filed, latest filing per fiscal year
Fiscal year endRevenue (¥bn)Profit (¥bn)Total assets (¥bn)EPS (¥)DPS (¥)Employees
2022-05-31755.423.2363.1584.7680.005,101
2023-05-31827.723.8421.0600.96100.005,290
2024-05-31965.024.5476.5308.61120.005,512
2025-05-311,011.431.0524.8390.8670.005,709
2026-05-311,099.632.0596.5404.3382.005,984

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON

Cross-shareholdings

Ten largest cross-shareholdings by book value, latest annual report
Company heldSharesBook value (¥bn)% of shares outstanding
TSURUHA HOLDINGS INC.1000.00.0
SUNDRUG CO.,LTD.1000.00.0
CREATE SD HOLDINGS CO.,LTD.1000.00.0
SUGI HOLDINGS CO.,LTD.1000.00.0
CAWACHI LIMITED1000.00.0

% of shares outstanding: shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown